Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 42 (4), 513-517

Serotonin-norepinephrine Reuptake Inhibitors and the Influence of Binding Affinity (Ki) on Analgesia

Affiliations

Serotonin-norepinephrine Reuptake Inhibitors and the Influence of Binding Affinity (Ki) on Analgesia

M Raouf et al. J Clin Pharm Ther.

Abstract

What is known and objective: Serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used for various psychiatric conditions and neuropathic pain syndromes. SNRIs inhibit the reuptake of serotonin (5-HT) and norepinephrine (NE); however, NE reuptake inhibition is thought to be the primary mediator for their analgesic effect.

Comment: Key differences in pharmacodynamics and receptor affinities exist between SNRIs. The selectivity for each monoamine differs among SNRIs based on the agent's affinity and activity at the monoamine reuptake transporter. We review differences in receptor affinities and monoamine selectivity among SNRIs and the corresponding clinical impact.

What is new and conclusion: The varying selectivity for 5-HT and NE among the SNRIs may help explain the therapeutic dosing required for neuropathic pain as well as dose-related adverse effects. It is important to understand the pharmacologic differences among SNRIs, in addition to the data from clinical trials, to guide their safe and effective use.

Keywords: antidepressants; binding affinity; neuropathic pain; pain; serotonin-norepinephrine reuptake inhibitors.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

MeSH terms

LinkOut - more resources

Feedback